$LLY: Decision Zone — Wedge Breakout or Retest of 685Eli Lilly (LLY) rebounded off the long-term trendline and weekly demand box (≈622–686) and is compressing inside a descending wedge.
Bullish path (blue): a clean break and retest of wedge resistance opens room toward the prior extension/marker near ~970.
Bearish path (red): rejection at the
Key facts today
Eli Lilly's obesity drugs, Mounjaro and Zepbound, were found less effective than Novo Nordisk's Wegovy in reducing heart attack and stroke risks, based on a study of over 21,000 patients.
0.58 CAD
14.51 B CAD
61.71 B CAD
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
CA28655A1066
FIGI
BBG01JDLZ5K4
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Lilly Has Fallen. Can it Get Up?Eli Lilly has been trending lower, and some traders may see further downside risk in the pharma giant.
The first pattern on today’s chart is the bearish gap on August 7. The decline came despite better-than-expected quarterly results, which may reflect weakening fundamentals.
Second is the May 23
Eli Lilly (LLY) Weekly Chart – Double Top Patterns & Major SuppoLLY has formed consecutive double top patterns within a broad descending channel.
Price recently tested a long-term major support zone and bounced strongly, signaling renewed buying interest. If this momentum holds, a move toward the major resistance near $973 is possible, aligning with the upper
LLY - Clean Levels UpdatedEli Lilly's hit those 708.49 and 711 levels I mentioned in my previous LLY post.
I've added some weekly levels, and a couple relevant spots from my boxed LLY chart.
If LLY loses steam up here we could easily see a retest of that box top area in the $680 - $678 range. Otherwise if we see a market
LLY $720 Call Setup: Don’t Miss Out on This Breakout Play!🚀 LLY Weekly Options Analysis (2025-08-17) 🚀
### 🔎 Comprehensive Multi-Model Insights
**Grok/xAI Report**
* 📊 RSI: Neutral (Daily & Weekly \~46)
* 📈 Flow: Call/Put = **3.87 (Bullish bias)**
* 🔊 Volume: Weak vs. previous weeks → ⚠️ no strong institutional support
* 🛑 Trade: **No entry** (weak conf
LLY AUG-2025Eli Lilly ( NYSE:LLY ) rebounded strongly from the 640 support zone after institutional absorption. Price is now targeting the gap at 740, aligning with prior distribution levels. Sustained momentum above 700 could drive continuation into 737–740. Failure to hold above 640 risks a deeper move into t
Red Pill or Blue Pill?Red Pill first - let’s stick to some harsh realities, but using technical analysis only.
Why the harsh crash?
We were rejected at the Value Area high at $972, followed by another rejection at the 0.786 Fibonacci level at $916, along with the top of the flag pattern of this giant bull flag. This wa
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
—
Maturity date
Feb 27, 2063
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064Yield to maturity
—
Maturity date
Aug 14, 2064
LLY6003479
Eli Lilly and Company 4.9% 12-FEB-2032Yield to maturity
—
Maturity date
Feb 12, 2032
LLY.GG
Eli Lilly and Company 6.77% 01-JAN-2036Yield to maturity
—
Maturity date
Jan 1, 2036
LLY6003396
Eli Lilly and Company 5.5% 12-FEB-2055Yield to maturity
—
Maturity date
Feb 12, 2055
LLY6003480
Eli Lilly and Company 4.55% 12-FEB-2028Yield to maturity
—
Maturity date
Feb 12, 2028
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065Yield to maturity
—
Maturity date
Feb 12, 2065
LLY5750404
Eli Lilly and Company 4.5% 09-FEB-2029Yield to maturity
—
Maturity date
Feb 9, 2029
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
—
Maturity date
May 15, 2047
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044Yield to maturity
—
Maturity date
Jun 15, 2044
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
—
Maturity date
Feb 9, 2064
See all LLY bonds